To determine whether ASPM expression is associated with survival outcomes in patients with KIRC, KIRP, LIHC, LUAD, and PAAD, we analyzed the correlation between the expression of ASPM and prognosis using samples from the OncoLnc and GEPIA databases, high ASPM expression was associated with a poor prognosis. The gene discussed is ASPM; the disease is pancreatic adenocarcinoma.